Protein Prenylation Constitutes an Endogenous Brake on Axonal Growth
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Suboptimal axonal regeneration contributes to the consequences of nervous system trauma and neurodegenerative disease, but the intrinsic mechanisms that regulate axon growth remain unclear. We screened 50,400 small molecules for their ability to promote axon outgrowth on inhibitory substrata. The most potent hits were the statins, which stimulated growth of all mouse- and human-patient-derived neurons tested, both in vitro and in vivo, as did combined inhibition of the protein prenylation enzymes farnesyltransferase (PFT) and geranylgeranyl transferase I (PGGT-1). Compensatory sprouting of motor axons may delay clinical onset of amyotrophic lateral sclerosis (ALS). Accordingly, elevated levels of PGGT1B, which would be predicted to reduce sprouting, were found in motor neurons of early- versus late-onset ALS patients postmortem. The mevalonate-prenylation pathway therefore constitutes an endogenous brake on axonal growth, and its inhibition provides a potential therapeutic approach to accelerate neuronal regeneration in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR Pathway
Park, K. K., Liu, K., Hu, Y., Smith, P. D., Wang, C., Cai, B., Xu, B., Connolly, L., Kramvis, I., Sahin, M., et al. (2008) · Science · doi:10.1126/science.1161566 · Cited by 1,686
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796 · cited 1×
“…Axonal Growth DownstreamofHMGCR,multiplebranches of themevalonate pathway lead to the synthesis of isoprenoids involved in the syn- thesis of cholesterol as well as lipid intermediates required for post-translational protein prenylation (Figure 3A; van der Most et al., 2009; Corsini et al., 1999).”
PTPσ Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration
Shen, Y., Tenney, A. P., Busch, S. A., Horn, K. P., Cuascut, F. X., Liu, K., He, Z., Silver, J., & Flanagan, J. G. (2009) · Science · doi:10.1126/science.1178310 · Cited by 682 · cited 1×
“Key components of the glial scar are the chondroitin sulfate proteoglycans (CSPGs), a family of extracellular matrix proteins that inhibit axon outgrowth (Dickendesher et al., 2012; Lang et al., 2014; Shen et al., 2009; Snow et al., 2003).”
Neuronal Intrinsic Mechanisms of Axon Regeneration
Liu, K., Tedeschi, A., Park, K. K., & He, Z. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113723 · Cited by 458 · cited 16×
“Moreover, those small molecules that have been shown to be effective in the CNS in vivo, such as cyclic AMP (cAMP)/ rolipram, ROCK inhibitor, and polyamines, lack the specificity and potency expected of clinical candidates (Fournier et al., 2003; Nikulina et al., 2004; Cai et al., 1999, 2002).”
InfluentialNgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans
Dickendesher, T. L., Baldwin, K. T., Mironova, Y. A., Koriyama, Y., Raiker, S. J., Askew, K. L., Wood, A., Geoffroy, C. G., Zheng, B., Liepmann, C. D., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3070 · Cited by 449 · cited 1×
“Key components of the glial scar are the chondroitin sulfate proteoglycans (CSPGs), a family of extracellular matrix proteins that inhibit axon outgrowth (Dickendesher et al., 2012; Lang et al., 2014; Shen et al., 2009; Snow et al., 2003).”
Statins: Mechanisms of neuroprotection
van der Most, P. J., Dolga, A. M., Nijholt, I. M., Luiten, P. G. M., & Eisel, U. L. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.002 · Cited by 268 · cited 1×
“…Axonal Growth DownstreamofHMGCR,multiplebranches of themevalonate pathway lead to the synthesis of isoprenoids involved in the syn- thesis of cholesterol as well as lipid intermediates required for post-translational protein prenylation (Figure 3A; van der Most et al., 2009; Corsini et al., 1999).”
Prior medical conditions and the risk of amyotrophic lateral sclerosis
Seelen, M., van Doormaal, P. T. C., Visser, A. E., Huisman, M. H. B., Roozekrans, M. H. J., de Jong, S. W., van der Kooi, A. J., de Visser, M., Voermans, N. C., Veldink, J. H., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7445-1 · Cited by 104
Butterfield, D. A., Barone, E., & Mancuso, C. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.04.007 · Cited by 80 · cited 2×
“But these concentrations, which are at least an order of magnitude above the EC50, were found to be toxic in our study and other studies (Figures 2C, 2D, and 3E; Butterfield et al., 2011).”
Cited by
CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons
Tian, R., Gachechiladze, M. A., Ludwig, C. H., Laurie, M. T., Hong, J. Y., Nathaniel, D., Prabhu, A. V., Fernandopulle, M. S., Patel, R., Abshari, M., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.014 · Cited by 543
Statins and the Brain: More than Lipid Lowering Agents?
Fracassi, A., Marangoni, M., Rosso, P., Pallottini, V., Fioramonti, M., Siteni, S., & Segatto, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170703101816 · Cited by 116
Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Godoy-Corchuelo, J. M., Fernández-Beltrán, L. C., Ali, Z., Gil-Moreno, M. J., López-Carbonero, J. I., Guerrero-Sola, A., Larrad-Sainz, A., Matias-Guiu, J., Matias-Guiu, J. A., Cunningham, T. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051105 · Cited by 35
“These results may be surprising since statins have been described as one of the most potent axonal regeneration-promoting compounds [72], and also are being considered for other neurodegenerative disorders since they also have anti-inflammatory and anti-oxidant properties, as well as attenuate the amyloid and protein…”
BackgroundSynthesis and NMR Characterization of the Prenylated Peptide, a-Factor
(2019) · Methods in Enzymology · doi:10.1016/bs.mie.2018.09.025 · Cited by 4
Metadata
- Authors
- Li, H., Kuwajima, T., Oakley, D., Nikulina, E., Hou, J., Yang, W. S., Lowry, E. R., Lamas, N. J., Amoroso, M. W., Croft, G. F., Hosur, R., Wichterle, H., Sebti, S., Filbin, M. T., Stockwell, B., & Henderson, C. E.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 16
- Issue
- 2
- Pages
- 545-558
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2461710273
- Cited by
- 57
- References
- 8
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protein Prenylation Constitutes an Endogenous Brake on Axonal Growth. https://app.cochat.ai/papers/10.1016/j.celrep.2016.06.013
- The paper
- Li, H., Kuwajima, T., Oakley, D., Nikulina, E., Hou, J., Yang, W. S., Lowry, E. R., Lamas, N. J., Amoroso, M. W., Croft, G. F., Hosur, R., Wichterle, H., Sebti, S., Filbin, M. T., Stockwell, B., & Henderson, C. E. (2016). Protein Prenylation Constitutes an Endogenous Brake on Axonal Growth. Cell Reports. https://doi.org/10.1016/j.celrep.2016.06.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.